Stock Price
244,500.00
Daily Change
-4,000.00 -1.61%
Monthly
13.72%
Yearly
29.16%
Q1 Forecast
232,247.40

Celltrion reported KRW1.55K in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q3 Sep/2025 1128.22 998.38 388.00 Oct/21 2025
FY2025Q2 Jun/2025 810.39 918.69 361.54 Jul/21 2025
FY2025Q1 Mar/2025 481.37 966.11 69.90 May/09 2025
FY2024Q3 Sep/2024 388.00 725.91 1085.1 Nov/12 2024
FY2024Q2 Jun/2024 361.54 256.00 1034 Aug/07 2024




Eps Change Date
Akebia Therapeutics USD 0.03 0.13 Mar/2025
Alaunos Therapeutics USD -0.53 0.07 Sep/2025
Avita Medical AUD -0.38 0.16 Jun/2025
Celltrion KRW 1.55K 422.43 Mar/2026
Dianthus Therapeutics USD -0.97 0.09 Sep/2025
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
IQVIA Holdings USD 3.42 0.42 Dec/2025
Moderna USD -2.11 1.6 Dec/2025
Organon & Co USD 0.63 0.38 Dec/2025
Revvity USD 1.7 0.52 Dec/2025
Tectonic Therapeutic USD -1.02 0.05 Sep/2025
Viatris USD 0.67 0.05 Sep/2025
Xeris Pharmaceuticals USD 0 0.02 Sep/2025